Calquence 100 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F9NS7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,580
Award facts
- Contract value 100% obligated
- $23,579.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $23.6K to AmerisourceBergen Drug Corp on January 30, 2026, for the supply of Calquence (acalabrutinib) 100 mg tablets in quantities of 60 units. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, with completion anticipated by February 23, 2026. The delivery order is executed under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion vehicle through December 2026 that serves as the primary mechanism for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor providing critical medical commodities to federal agencies. The company's extensive federal contract portfolio demonstrates its capability to deliver a comprehensive range of products including specialty medications, brand-name and generic drugs, and vaccines across multiple therapeutic domains. Through its DLA contract vehicle and other federal agreements, AmerisourceBergen supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positioning it as a key vendor in the federal medical supply chain serving military treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F9NS7?
SPE2DR26F9NS7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F9NS7 worth?
The government has obligated $23,580 on SPE2DR26F9NS7.
Is contract SPE2DR26F9NS7 an order under another contract?
Yes. SPE2DR26F9NS7 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9NS7 competed?
The extent of competition for SPE2DR26F9NS7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award